secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2022-05-13T23:59:59+00:00
Accession:  0001493152-22-013253
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Philip Palmedo will not stand for reelection at Lixte's upcoming Annual Meeting
--------------------------------------------------------------------------------

- Philip Palmedo informed Lixte on May 9, 2022 that he will not seek reelection at the next Annual Meeting.
- He will continue serving as a director until the Annual Meeting date.
- Dr. Palmedo had served as a director since June 30, 2006, over 15 years.
- No reason for the decision was disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315222013253/0001493152-22-013253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315222013253/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-013253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer